We don’t think that genomic startups should be spending money building a lab, hiring technicians, and burning up capital to generate the data they need to prove out their concept.
MURRIETA, Calif. (PRWEB)
September 01, 2020
Murrieta Genomics, the launch pad for genomic sequencing startups has become a Media Sponsor for the three day Digital RESI (Redefining Early Stage Investments) Conference being held virtually September 14, 15 and 16.
“Murrieta Genomics was formed to launch great genomic sequencing companies,” stated Jay Goth, CEO of Murrieta Genomics. “We believe that we are in the very early phase of precision medicine and genomic sequencing is one of the fundamental technologies driving this new trend. Life Science Nation provides an incredibly important service to early stage life science companies by connecting them with products, services and capital.”
The event is hosted by Life Science Nation (LSN) who has pioneered a unique global partnering event model that matches buyers and sellers based on their specifically stated needs and declared partnering mandate initiatives garnered from one-on-one interviews and curating buyer/seller databases in a selected industry.
RESI is the largest partnering conference in North America focusing on early-stage life science investments and strategic partnerships and has around 2000 global investors and channel partners that regularly attend 2-3 RESI conferences a year. LSN estimates that over 300 companies have raised over $400mm dollars by including RESI as part of their fundraising strategy.
The digital partnering event is an innovative approach to partnering that was developed in response to the current Coronavirus pandemic. LSN has had to shift their planned Boston event to a digital platform due to the restrictions on travel and found that opening the conference to a virtual audience was a game changer.
“Digital RESI Global doubled our predicted attendee turnout with investment partners and fundraising CEOs. The metrics are actually quite interesting and surprised us in revealing the pent-up demand for action in the life science arena in these troubled times,” stated Dennis Ford, founder and CEO of Life Science Nation. “I never would have thought that these troubled times would have contributed to a new model that seems to be shifting the paradigm.”
Murrieta Genomics is on the lookout for new potential candidates for the incubator. “We can offer genomic startups critical resources that most life science incubators and accelerators don’t,” said Goth. “For example, our advisory board is comprised of industry leaders – not only in the genomic and science areas, but also in necessary fields including legal, accounting, human resources and investment banking.”
“We don’t think that genomic startups should be spending money building a lab, hiring technicians, and burning up capital to generate the data they need to prove out their concept. We offer them the sequencing know-how and access to resources that would normally be cost prohibitive with no bench fees or overhead costs except for hard costs such as reagents. People with genomic domain knowledge can prove their science while building a business model before reaching out to investors.”
Early stage life science companies can register for the Digital RESI conference here and use the promo code “MG10” to save 10% off of registration fees.
About Murrieta Genomics
Murrieta Genomics provides access to next generation sequencing technology for researchers in the health, veterinary, agriculture, forensics and direct to consumer industries. The company is a true business incubator, offering mentorship and guidance from both the scientific and business perspective to aspiring genomic-related entrepreneurs. The founders of Murrieta Genomics have extensive background in business, finance, science and technology. They are supplemented with a prestigious advisory board from both business and science. The company provides Next Generation Sequencing (NGS) services, hands-on consulting, review, appraisal, and guidance. In addition, it provides help with company value propositions and potential seed funding support to qualified incubator graduates. For more information visit http://www.murrietagenomics.com.
Murrieta Genomics is part of the Murrieta Innovation Center, a building owned by the city of Murrieta and dedicated to supporting life science companies. The Innovation Center has medical device, therapeutic, software, clinical research and of course genomic companies that are working hard to advance new ideas and innovations that can impact the world in a positive way. The Center is also a resource for all types of local startup companies, offering services and workshops from a local SBDC, several veteran organizations, a SCORE branch and more.
About Life Science Nation’s RESI Conference
The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What is unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics, and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.
Share article on social media or email: